BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

753 related articles for article (PubMed ID: 25633981)

  • 1. Functional and molecular characterisation of EO771.LMB tumours, a new C57BL/6-mouse-derived model of spontaneously metastatic mammary cancer.
    Johnstone CN; Smith YE; Cao Y; Burrows AD; Cross RS; Ling X; Redvers RP; Doherty JP; Eckhardt BL; Natoli AL; Restall CM; Lucas E; Pearson HB; Deb S; Britt KL; Rizzitelli A; Li J; Harmey JH; Pouliot N; Anderson RL
    Dis Model Mech; 2015 Mar; 8(3):237-51. PubMed ID: 25633981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional and Phenotypic Characterisations of Common Syngeneic Tumour Cell Lines as Estrogen Receptor-Positive Breast Cancer Models.
    Lambouras M; Roelofs C; Pereira M; Gruber E; Vieusseux JL; Lanteri P; Johnstone CN; Muntz F; O'Toole S; Ooms LM; Mitchell CA; Anderson RL; Britt KL
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The serine protease inhibitor protease nexin-1 controls mammary cancer metastasis through LRP-1-mediated MMP-9 expression.
    Fayard B; Bianchi F; Dey J; Moreno E; Djaffer S; Hynes NE; Monard D
    Cancer Res; 2009 Jul; 69(14):5690-8. PubMed ID: 19584287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bcl-2/adenovirus E1B 19 kDa interacting protein-3 knockdown enables growth of breast cancer metastases in the lung, liver, and bone.
    Manka D; Spicer Z; Millhorn DE
    Cancer Res; 2005 Dec; 65(24):11689-93. PubMed ID: 16357180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation and characterisation of two D2A1 mammary cancer sublines to model spontaneous and experimental metastasis in a syngeneic BALB/c host.
    Jungwirth U; van Weverwijk A; Melake MJ; Chambers AF; Gao Q; Fivaz M; Isacke CM
    Dis Model Mech; 2018 Jan; 11(1):. PubMed ID: 29208627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic plasticity of metastatic breast cancer cells: adaptation to changes in the microenvironment.
    Simões RV; Serganova IS; Kruchevsky N; Leftin A; Shestov AA; Thaler HT; Sukenick G; Locasale JW; Blasberg RG; Koutcher JA; Ackerstaff E
    Neoplasia; 2015 Aug; 17(8):671-84. PubMed ID: 26408259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Panax notoginseng saponins (PNS) inhibits breast cancer metastasis.
    Wang P; Cui J; Du X; Yang Q; Jia C; Xiong M; Yu X; Li L; Wang W; Chen Y; Zhang T
    J Ethnopharmacol; 2014 Jul; 154(3):663-71. PubMed ID: 24793216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelial-mesenchymal transition (EMT) is not sufficient for spontaneous murine breast cancer metastasis.
    Lou Y; Preobrazhenska O; auf dem Keller U; Sutcliffe M; Barclay L; McDonald PC; Roskelley C; Overall CM; Dedhar S
    Dev Dyn; 2008 Oct; 237(10):2755-68. PubMed ID: 18773493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgically-Induced Multi-organ Metastasis in an Orthotopic Syngeneic Imageable Model of 4T1 Murine Breast Cancer.
    Zhang Y; Zhang N; Hoffman RM; Zhao M
    Anticancer Res; 2015 Sep; 35(9):4641-6. PubMed ID: 26254353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour but not stromal expression of β3 integrin is essential, and is required early, for spontaneous dissemination of bone-metastatic breast cancer.
    Carter RZ; Micocci KC; Natoli A; Redvers RP; Paquet-Fifield S; Martin AC; Denoyer D; Ling X; Kim SH; Tomasin R; Selistre-de-Araújo H; Anderson RL; Pouliot N
    J Pathol; 2015 Apr; 235(5):760-72. PubMed ID: 25430721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using an in-vivo syngeneic spontaneous metastasis model identifies ID2 as a promoter of breast cancer colonisation in the brain.
    Kijewska M; Viski C; Turrell F; Fitzpatrick A; van Weverwijk A; Gao Q; Iravani M; Isacke CM
    Breast Cancer Res; 2019 Jan; 21(1):4. PubMed ID: 30642388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrin-linked kinase regulates osteopontin-dependent MMP-2 and uPA expression to convey metastatic function in murine mammary epithelial cancer cells.
    Mi Z; Guo H; Wai PY; Gao C; Kuo PC
    Carcinogenesis; 2006 Jun; 27(6):1134-45. PubMed ID: 16474180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-renewal gene tracking to identify tumour-initiating cells associated with metastatic potential.
    Darini CY; Pisani DF; Hofman P; Pedeutour F; Sudaka I; Chomienne C; Dani C; Ladoux A
    Oncogene; 2012 May; 31(19):2438-49. PubMed ID: 21927026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exon-based clustering of murine breast tumor transcriptomes reveals alternative exons whose expression is associated with metastasis.
    Dutertre M; Lacroix-Triki M; Driouch K; de la Grange P; Gratadou L; Beck S; Millevoi S; Tazi J; Lidereau R; Vagner S; Auboeuf D
    Cancer Res; 2010 Feb; 70(3):896-905. PubMed ID: 20103641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epithelial-mesenchymal plasticity is a decisive feature for the metastatic outgrowth of disseminated WAP-T mouse mammary carcinoma cells.
    Maenz C; Lenfert E; Pantel K; Schumacher U; Deppert W; Wegwitz F
    BMC Cancer; 2015 Mar; 15():178. PubMed ID: 25886487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted Pten deletion plus p53-R270H mutation in mouse mammary epithelium induces aggressive claudin-low and basal-like breast cancer.
    Wang S; Liu JC; Kim D; Datti A; Zacksenhaus E
    Breast Cancer Res; 2016 Jan; 18(1):9. PubMed ID: 26781438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 deficiency linked to B cell translocation gene 2 (BTG2) loss enhances metastatic potential by promoting tumor growth in primary and metastatic sites in patient-derived xenograft (PDX) models of triple-negative breast cancer.
    Powell E; Shao J; Yuan Y; Chen HC; Cai S; Echeverria GV; Mistry N; Decker KF; Schlosberg C; Do KA; Edwards JR; Liang H; Piwnica-Worms D; Piwnica-Worms H
    Breast Cancer Res; 2016 Jan; 18(1):13. PubMed ID: 26818199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactivation of multipotency by oncogenic PIK3CA induces breast tumour heterogeneity.
    Van Keymeulen A; Lee MY; Ousset M; Brohée S; Rorive S; Giraddi RR; Wuidart A; Bouvencourt G; Dubois C; Salmon I; Sotiriou C; Phillips WA; Blanpain C
    Nature; 2015 Sep; 525(7567):119-23. PubMed ID: 26266985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting fibroblast growth factor receptors blocks PI3K/AKT signaling, induces apoptosis, and impairs mammary tumor outgrowth and metastasis.
    Dey JH; Bianchi F; Voshol J; Bonenfant D; Oakeley EJ; Hynes NE
    Cancer Res; 2010 May; 70(10):4151-62. PubMed ID: 20460524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mouse mammary carcinoma 4T1: characterization of the cellular landscape of primary tumours and metastatic tumour foci.
    DuPré SA; Redelman D; Hunter KW
    Int J Exp Pathol; 2007 Oct; 88(5):351-60. PubMed ID: 17877537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.